Share-based payment contracts are a common feature of employee remuneration and incentive schemes, often involving an entity's own equity instruments. While IFRS 2 Share-based Payment provides specific guidance for these transactions, some contracts can contain features that behave like derivatives. This introduces a critical question: when does IFRS 2 apply, and when do the rules of IFRS 9 Financial Instruments, particularly those for embedded derivatives, take over?
The Intersection of Two Key Standards
The interaction between IFRS 2 and IFRS 9 regarding embedded derivatives is a nuanced area. IFRS 2's primary objective is to specify the financial reporting by an entity when it undertakes a share-based payment transaction. It covers equity-settled, cash-settled, and those with a choice of settlement. However, IFRS 2 contains scope exclusions that direct entities to other standards for certain financial instruments.
IFRS 9, on the other hand, sets out the principles for the financial reporting of financial assets and financial liabilities, including derivatives. A core concept in IFRS 9 is the treatment of 'embedded derivatives' – features within a host contract that modify the cash flows in a manner similar to a standalone derivative. If an embedded derivative is not 'closely related' to its host and the combined contract is not measured at fair value through profit or loss (FVTPL), IFRS 9 typically requires it to be separated and accounted for as a standalone derivative.
The 'Own Equity' Distinction: The Crucial Link
The key to understanding the interaction lies in how the share-based payment contract (including any embedded feature) is classified from the issuer's perspective. Specifically, does the contract, with all its terms, meet the definition of an 'equity instrument of the entity' as defined in IAS 32 Financial Instruments: Presentation and applied through IFRS 9? This is the gatekeeper.
If the share-based payment contract, *including* the embedded derivative feature, continues to meet the definition of an 'equity instrument' of the entity, then IFRS 2 generally applies to the entire contract. In this scenario, the embedded derivative is not separated and accounted for under IFRS 9. For instance, a simple share option granted to an employee is an equity-settled share-based payment under IFRS 2, even though it has derivative-like characteristics, because it leads to the issuance of the entity's own equity instrument.
When IFRS 9 Steps In
IFRS 9's rules for embedded derivatives become relevant if, due to the embedded feature, the share-based payment contract *no longer meets the definition of an equity instrument* of the entity. This can occur in complex situations, such as:
* **Net cash settlement provisions:** If the contract requires or permits net cash settlement, or provides for settlement by exchanging a variable number of the entity's own equity instruments whose value equals a fixed amount, it may not be an equity instrument.
* **Specific repurchase obligations:** If the entity has an obligation to repurchase the shares issued at a fixed price, potentially creating a financial liability rather than an equity instrument.
In these scenarios, if the embedded derivative causes the *host contract* to fail equity classification, and if that embedded derivative is not 'closely related' to its host contract and the combined instrument isn't already measured at FVTPL, then IFRS 9 would require the embedded derivative to be separated and accounted for at FVTPL. The host contract would then be assessed under other relevant IFRS 9 guidance.
Practical Considerations
It's important to differentiate this from cash-settled share-based payments that are explicitly within the scope of IFRS 2. Even though these are accounted for as liabilities, they remain under IFRS 2. The critical point for IFRS 9 interaction is when an embedded feature makes an *otherwise equity-linked* transaction fail the 'own equity' classification, thus potentially taking it out of the full scope of IFRS 2 for that specific embedded component.
Ultimately, a thorough review of the contractual terms and conditions against the 'own equity' criteria under IAS 32/IFRS 9 is paramount. Most standard share-based payment features will fall entirely within IFRS 2. However, any unusual or complex embedded features require careful analysis to determine if IFRS 9's embedded derivative rules are triggered, ensuring accurate financial reporting for these intricate arrangements.
Need Help With Your IFRS 2 Valuation?
Our qualified actuaries can help you with discount rate selection, assumption setting, and full IFRS 2 valuations.
Get a Quote